Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122,803 | 46 | 59.0% |
| Travel and Lodging | $46,800 | 106 | 22.5% |
| Consulting Fee | $25,690 | 9 | 12.3% |
| Food and Beverage | $12,381 | 346 | 5.9% |
| Honoraria | $555.00 | 1 | 0.3% |
| Education | $42.08 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $112,532 | 125 | $0 (2024) |
| CSL Behring | $86,769 | 225 | $0 (2024) |
| ARGENX US, INC. | $4,185 | 20 | $0 (2024) |
| UCB, Inc. | $1,960 | 18 | $0 (2024) |
| Biogen, Inc. | $257.16 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $173.42 | 3 | $0 (2024) |
| Akcea Therapeutics, Inc. | $156.15 | 1 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $145.28 | 6 | $0 (2021) |
| Allergan, Inc. | $136.71 | 9 | $0 (2022) |
| GENZYME CORPORATION | $116.70 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147,144 | 230 | Alexion Pharmaceuticals, Inc. ($90,269) |
| 2023 | $34,788 | 134 | CSL Behring ($22,814) |
| 2022 | $24,456 | 86 | Alexion Pharmaceuticals, Inc. ($12,429) |
| 2021 | $1,324 | 42 | CSL Behring ($725.75) |
| 2020 | $223.36 | 13 | Allergan, Inc. ($30.65) |
| 2019 | $336.29 | 7 | Akcea Therapeutics, Inc. ($156.15) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,145.00 | General |
| Category: Immunology | ||||||
| 12/20/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,145.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Rare Disease | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | In-kind items and services | $825.70 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | In-kind items and services | $602.95 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | In-kind items and services | $136.85 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $24.43 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $24.28 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,862.50 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $427.98 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $304.18 | General |
| Category: Immunology | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $37.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $23.93 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $21.55 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $19.78 | General |
| Category: Immunology | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $19.62 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | EMGALITY (Drug), AMYVID, REYVOW | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Immunology | ||||||
| 12/09/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $3.61 | General |
| Category: Immunology | ||||||
| 12/06/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $26.90 | General |
| Category: Immunology | ||||||
| 12/06/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $24.26 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 374 | 455 | $154,818 | $37,723 |
| 2022 | 7 | 200 | 226 | $51,346 | $14,005 |
| 2021 | 11 | 333 | 438 | $111,001 | $32,054 |
| 2020 | 11 | 292 | 344 | $100,428 | $36,944 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 67 | $28,155 | $7,644 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 88 | $26,510 | $7,404 | 27.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 50 | 51 | $19,110 | $4,692 | 24.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 83 | 105 | $21,173 | $4,490 | 21.2% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 25 | 25 | $16,465 | $3,343 | 20.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $12,480 | $3,318 | 26.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 21 | 21 | $11,280 | $2,892 | 25.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 24 | 24 | $11,775 | $2,448 | 20.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 32 | 38 | $5,070 | $849.90 | 16.8% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 11 | 12 | $2,800 | $644.23 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 46 | $8,970 | $2,962 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 24 | $6,360 | $2,724 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 25 | $5,095 | $1,798 | 35.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 19 | 19 | $7,805 | $1,547 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $3,075 | $1,219 | 39.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 12 | 12 | $6,180 | $1,085 | 17.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 28 | 34 | $5,911 | $1,075 | 18.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 18 | 21 | $3,675 | $733.29 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,755 | $616.96 | 35.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 17 | 21 | $2,520 | $244.38 | 9.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 77 | $20,405 | $8,341 | 40.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 78 | $15,210 | $5,889 | 38.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $12,375 | $4,518 | 36.5% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 25 | 26 | $18,980 | $3,797 | 20.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 62 | 78 | $13,416 | $2,841 | 21.2% |
About Dr. Christopher Scheiner, MD
Dr. Christopher Scheiner, MD is a Neurology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487864773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Scheiner, MD has received a total of $208,270 in payments from pharmaceutical and medical device companies, with $147,144 received in 2024. These payments were reported across 512 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($122,803).
As a Medicare-enrolled provider, Scheiner has provided services to 1,199 Medicare beneficiaries, totaling 1,463 services with total Medicare billing of $120,726. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Dayton, OH
- Active Since 05/23/2007
- Last Updated 01/20/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487864773
Products in Payments
- Hizentra (Biological) $86,714
- ULTOMIRIS (Biological) $82,652
- VYVGART (Drug) $3,925
- SOLIRIS (Biological) $3,450
- Zilbrysq (Biological) $1,260
- VYVGART HYTRULO (Drug) $225.92
- NURTEC ODT (Drug) $209.88
- BOTOX (Biological) $187.62
- ZEPOSIA (Drug) $172.62
- Soliris (Drug) $157.24
- TEGSEDI (Drug) $156.15
- Rystiggo (Drug) $146.05
- Briviact (Drug) $131.33
- SOLIRIS (Drug) $128.65
- Fintepla (Drug) $98.08
- VALTOCO (Drug) $93.86
- Nayzilam (Drug) $86.00
- Spinraza (Biological) $86.00
- KESIMPTA (Drug) $85.64
- SPINRAZA (Biological) $78.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dayton
Dr. Lawrence Goldstick, Md, MD
Neurology — Payments: $859,566
Dr. Tracy Eicher, M.d, M.D
Neurology — Payments: $361,598
Richard Kim, M.d, M.D
Neurology — Payments: $288,010
Joel Vandersluis, M.d, M.D
Neurology — Payments: $66,506
Dr. Steven Arkin, M.d, M.D
Neurology — Payments: $39,074
Dr. Drew Dula, D.o, D.O
Neurology — Payments: $13,170